Table 1 Patient clinical and demographic information
Mean age | 51.3 ± 11.9 |
|---|---|
Premenopausal | 18 (43%) |
Postmenopausal | 24 (57%) |
Tumour localisation | |
Central | 8 (19%) |
Upper outer quadrant | 19 (45%) |
Lower outer quadrant | 3 (7%) |
Upper inner quadrant | 6 (14%) |
Lower inner quadrant | 5 (12%) |
Mammographic BI-RADS | |
BI-RADS 0 | 7 (17%) |
BI-RADS 3 | 2 (5%) |
BI-RADS 4a | 2 (5%) |
BI-RADS 4b | 2 (5%) |
BI-RADS 4c | 7 (17%) |
BI-RADS 5 | 21 (50%) |
Ultrasonography BI-RADS | |
BI-RADS 0 | 1 (2%) |
BI-RADS 3 | 1 (2%) |
BI-RADS 4a | 3 (7%) |
BI-RADS 4b | 3 (7%) |
BI-RADS 4c | 13 (31%) |
BI-RADS 5 | 21 (50%) |
Lumpectomy + SLN | 19 (45%) |
Lumpectomy + AD | 12 (29%) |
Mastectomy + SLN | 3 (7%) |
Mastectomy + AD | 8 (19%) |
Tumour diameter (T) | |
T1a | 0 |
T1b | 3 (7%) |
T1c | 12 (29%) |
T2 | 27 (64%) |
Tumour histology | |
Invasive Ductal | 38 (90%) |
Invasive Lobular | 1 (2%) |
Mucinous carcinoma | 2 (5%) |
Squamous cell carcinoma | 1 (2%) |